chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 55.0
Sex: F
Vaccine: COVID19
Symptoms: Eczema, Erythema, Fungal skin infection, Laboratory test normal, Pruritus
Clinical narrative: I began experiencing skin issues in the weeks/months after my booster. Extreme itching, red scaly patches on face, arms, legs. Also eczema type bumps on torso.  Also psoriasis on scalp.  Additionally yeast infection in arm pits that won't resolve with prescriptions ointments.
Age: 55.0
Sex: F
Vaccine: COVID19
Symptoms: Psoriasis, Skin disorder, Skin exfoliation
Clinical narrative: I began experiencing skin issues in the weeks/months after my booster. Extreme itching, red scaly patches on face, arms, legs. Also eczema type bumps on torso.  Also psoriasis on scalp.  Additionally yeast infection in arm pits that won't resolve with prescriptions ointments.
Age: 61.0
Sex: F
Vaccine: COVID19
Symptoms: Biopsy, Discharge, Ultrasound uterus abnormal, Uterine dilation and curettage, Uterine disorder
Clinical narrative: On Saturday after the vaccine, I had discharge, I called the doctor, I went to see the doctor, they did a biopsy and sent it to the lab, by the end of the week the result came back and the result was negative, no bad cells. He said it could be the vaccine could affect the uterus. He sent me to a cancer specialist, and he did a DNC and cleaned my uterus. I will do a follow up in December to make sure my uterus is not ticked.
Age: 74.0
Sex: F
Vaccine: COVID19-2
Symptoms: Injection site erythema
Clinical narrative: redness below injection site, spread up to injection site
Age: 73.0
Sex: M
Vaccine: COVID19
Symptoms: Incorrect product formulation administered
Clinical narrative: Initial COVID-19 vaccination was given instead of the booster. No adverse events reported.
Age: 80.0
Sex: F
Vaccine: COVID19-2
Symptoms: Cellulitis
Clinical narrative: cellulitis of arm- antibiotic treatment
Age: 59.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Acute respiratory distress syndrome, Acute respiratory failure, Anticoagulant therapy, Blood gases, COVID-19
Clinical narrative: 4/24/2022-Presented to ED, unwitnessed fall states hit head large hematoma on L eye, admitted to drinking alcohol daily. Confused. CT Had, R parafalcine subdural and L frontal/parietal subdural hygroma. CT-sacral fracture and L subtrochanteric femur fx. Covid -test.  Baseline 02 use 2L NC. Increased to 3L intermittently desat to mid 80's.Admit intraparenchymal hemorrhage with subdural hematoma s/t to fall.  4/25/2022-Left subtrochanteric hip fracture repair. R occiptal intraparenchymal hemorrhage inceased to 1.5cm L anterior frontal intraparenchymal hemorrhage increased to 5mm. No surgical intervention. BP controlled less then 140/80  currently 104/62, o2 sat 90's on 3L NC.  Keppra 750mg BID. ST eval clear liquids, swallowing difficulties. 4/26/2022- R occipital intraparenchymal hemorrhage  stable on f/u CT.  4/27/2022-On NRB, sat in mid 70's, o2 changed to 5L sata now 88-92%.  4/28/2022-AM-Mentation decline, desat 70-80 becoming more altered, fine wheezes bilateral and creptation on R side. Placed on NRB 15L. CXR-mod airpace disease/infiltrates  LAsix IV and levaquin , CT no evidence of PE. IVC filter placed to prevent PEd/t recent surgery and immobility.  PM-Sats in high 90's with NRB, but patient would not keep on, desatting to 70's. 5L NC was placed so suctioning could occur, sats would not maintain over 70%, thick yellow sputum obtained by suction. Became tachy and transfered to ICU and intubated.  Acute on chronic hypoxemic resp failure s/t to ARDS d/t pneumonia vs pulm edema in setting of HFrEF and AMS. Current bilevel  setting FiO2 60%.  4/29/2022-Bilevel 16 25/10 35%. WBC and h&h stable. On Vanco cefepime and flagyl.  4/30/2022- recent echo showed severe L ventricular dilatation with moderate miral regurg EF 20%. Continue entresto hold toresemide 5/2/2022- Exubated on 2L NC. Continue cefepime and flagyl. 5/3/2022- WBC 15.4 from 13.3  ABG 7.453/31.9/66/22.3/90 cxr-pulmonary vascular congestion and cardiomegaly. Cont digoxin and metoprolol 5/5/2022- Transfered to ICU. Wears bipap at HS. o2 sat on 2L stable.  5/13/2022- Rapid response called  Acute RF, hypoxic 80's on sat , tachypneic using resp muscles. BP 154/104  RR 24  ABG 7.45/25/97/18/ on NRB  worsening CT chest -pulmonary infiltrates and b/l pleural effusion.  Bipap with PEEP 8.   Continued  distress, intubated and transfered to ICU. Chest Ct consisten with b/l diffuse groundglass opacities/  Covid + test.  Ferritin 535.0. Started on steroids, barcitinib, remdesivir, vitamins and heparin.  Cefepime and Vanco. 5/15/2022- Vent 12 22/6 60% 5/17/2022-Palliative orders placed d/t severe HF and mitral valve issues, fluid is in lungs and she is at high risk for reintubation if extubation is attempted. Terminally exubated. Morphine increased.  WBC 15.5  5/19/2022- Time of death  1003.
Age: 59.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Cardiac failure, Cardiomegaly, Cerebral haemorrhage, Chest X-ray abnormal, Computerised tomogram abnormal
Clinical narrative: 4/24/2022-Presented to ED, unwitnessed fall states hit head large hematoma on L eye, admitted to drinking alcohol daily. Confused. CT Had, R parafalcine subdural and L frontal/parietal subdural hygroma. CT-sacral fracture and L subtrochanteric femur fx. Covid -test.  Baseline 02 use 2L NC. Increased to 3L intermittently desat to mid 80's.Admit intraparenchymal hemorrhage with subdural hematoma s/t to fall.  4/25/2022-Left subtrochanteric hip fracture repair. R occiptal intraparenchymal hemorrhage inceased to 1.5cm L anterior frontal intraparenchymal hemorrhage increased to 5mm. No surgical intervention. BP controlled less then 140/80  currently 104/62, o2 sat 90's on 3L NC.  Keppra 750mg BID. ST eval clear liquids, swallowing difficulties. 4/26/2022- R occipital intraparenchymal hemorrhage  stable on f/u CT.  4/27/2022-On NRB, sat in mid 70's, o2 changed to 5L sata now 88-92%.  4/28/2022-AM-Mentation decline, desat 70-80 becoming more altered, fine wheezes bilateral and creptation on R side. Placed on NRB 15L. CXR-mod airpace disease/infiltrates  LAsix IV and levaquin , CT no evidence of PE. IVC filter placed to prevent PEd/t recent surgery and immobility.  PM-Sats in high 90's with NRB, but patient would not keep on, desatting to 70's. 5L NC was placed so suctioning could occur, sats would not maintain over 70%, thick yellow sputum obtained by suction. Became tachy and transfered to ICU and intubated.  Acute on chronic hypoxemic resp failure s/t to ARDS d/t pneumonia vs pulm edema in setting of HFrEF and AMS. Current bilevel  setting FiO2 60%.  4/29/2022-Bilevel 16 25/10 35%. WBC and h&h stable. On Vanco cefepime and flagyl.  4/30/2022- recent echo showed severe L ventricular dilatation with moderate miral regurg EF 20%. Continue entresto hold toresemide 5/2/2022- Exubated on 2L NC. Continue cefepime and flagyl. 5/3/2022- WBC 15.4 from 13.3  ABG 7.453/31.9/66/22.3/90 cxr-pulmonary vascular congestion and cardiomegaly. Cont digoxin and metoprolol 5/5/2022- Transfered to ICU. Wears bipap at HS. o2 sat on 2L stable.  5/13/2022- Rapid response called  Acute RF, hypoxic 80's on sat , tachypneic using resp muscles. BP 154/104  RR 24  ABG 7.45/25/97/18/ on NRB  worsening CT chest -pulmonary infiltrates and b/l pleural effusion.  Bipap with PEEP 8.   Continued  distress, intubated and transfered to ICU. Chest Ct consisten with b/l diffuse groundglass opacities/  Covid + test.  Ferritin 535.0. Started on steroids, barcitinib, remdesivir, vitamins and heparin.  Cefepime and Vanco. 5/15/2022- Vent 12 22/6 60% 5/17/2022-Palliative orders placed d/t severe HF and mitral valve issues, fluid is in lungs and she is at high risk for reintubation if extubation is attempted. Terminally exubated. Morphine increased.  WBC 15.5  5/19/2022- Time of death  1003.
Age: 59.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Computerised tomogram head abnormal, Computerised tomogram thorax abnormal, Confusional state, Crepitations, Death
Clinical narrative: 4/24/2022-Presented to ED, unwitnessed fall states hit head large hematoma on L eye, admitted to drinking alcohol daily. Confused. CT Had, R parafalcine subdural and L frontal/parietal subdural hygroma. CT-sacral fracture and L subtrochanteric femur fx. Covid -test.  Baseline 02 use 2L NC. Increased to 3L intermittently desat to mid 80's.Admit intraparenchymal hemorrhage with subdural hematoma s/t to fall.  4/25/2022-Left subtrochanteric hip fracture repair. R occiptal intraparenchymal hemorrhage inceased to 1.5cm L anterior frontal intraparenchymal hemorrhage increased to 5mm. No surgical intervention. BP controlled less then 140/80  currently 104/62, o2 sat 90's on 3L NC.  Keppra 750mg BID. ST eval clear liquids, swallowing difficulties. 4/26/2022- R occipital intraparenchymal hemorrhage  stable on f/u CT.  4/27/2022-On NRB, sat in mid 70's, o2 changed to 5L sata now 88-92%.  4/28/2022-AM-Mentation decline, desat 70-80 becoming more altered, fine wheezes bilateral and creptation on R side. Placed on NRB 15L. CXR-mod airpace disease/infiltrates  LAsix IV and levaquin , CT no evidence of PE. IVC filter placed to prevent PEd/t recent surgery and immobility.  PM-Sats in high 90's with NRB, but patient would not keep on, desatting to 70's. 5L NC was placed so suctioning could occur, sats would not maintain over 70%, thick yellow sputum obtained by suction. Became tachy and transfered to ICU and intubated.  Acute on chronic hypoxemic resp failure s/t to ARDS d/t pneumonia vs pulm edema in setting of HFrEF and AMS. Current bilevel  setting FiO2 60%.  4/29/2022-Bilevel 16 25/10 35%. WBC and h&h stable. On Vanco cefepime and flagyl.  4/30/2022- recent echo showed severe L ventricular dilatation with moderate miral regurg EF 20%. Continue entresto hold toresemide 5/2/2022- Exubated on 2L NC. Continue cefepime and flagyl. 5/3/2022- WBC 15.4 from 13.3  ABG 7.453/31.9/66/22.3/90 cxr-pulmonary vascular congestion and cardiomegaly. Cont digoxin and metoprolol 5/5/2022- Transfered to ICU. Wears bipap at HS. o2 sat on 2L stable.  5/13/2022- Rapid response called  Acute RF, hypoxic 80's on sat , tachypneic using resp muscles. BP 154/104  RR 24  ABG 7.45/25/97/18/ on NRB  worsening CT chest -pulmonary infiltrates and b/l pleural effusion.  Bipap with PEEP 8.   Continued  distress, intubated and transfered to ICU. Chest Ct consisten with b/l diffuse groundglass opacities/  Covid + test.  Ferritin 535.0. Started on steroids, barcitinib, remdesivir, vitamins and heparin.  Cefepime and Vanco. 5/15/2022- Vent 12 22/6 60% 5/17/2022-Palliative orders placed d/t severe HF and mitral valve issues, fluid is in lungs and she is at high risk for reintubation if extubation is attempted. Terminally exubated. Morphine increased.  WBC 15.5  5/19/2022- Time of death  1003.
Age: 59.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Dysphagia, Echocardiogram abnormal, Endotracheal intubation, Eye haematoma, Fall
Clinical narrative: 4/24/2022-Presented to ED, unwitnessed fall states hit head large hematoma on L eye, admitted to drinking alcohol daily. Confused. CT Had, R parafalcine subdural and L frontal/parietal subdural hygroma. CT-sacral fracture and L subtrochanteric femur fx. Covid -test.  Baseline 02 use 2L NC. Increased to 3L intermittently desat to mid 80's.Admit intraparenchymal hemorrhage with subdural hematoma s/t to fall.  4/25/2022-Left subtrochanteric hip fracture repair. R occiptal intraparenchymal hemorrhage inceased to 1.5cm L anterior frontal intraparenchymal hemorrhage increased to 5mm. No surgical intervention. BP controlled less then 140/80  currently 104/62, o2 sat 90's on 3L NC.  Keppra 750mg BID. ST eval clear liquids, swallowing difficulties. 4/26/2022- R occipital intraparenchymal hemorrhage  stable on f/u CT.  4/27/2022-On NRB, sat in mid 70's, o2 changed to 5L sata now 88-92%.  4/28/2022-AM-Mentation decline, desat 70-80 becoming more altered, fine wheezes bilateral and creptation on R side. Placed on NRB 15L. CXR-mod airpace disease/infiltrates  LAsix IV and levaquin , CT no evidence of PE. IVC filter placed to prevent PEd/t recent surgery and immobility.  PM-Sats in high 90's with NRB, but patient would not keep on, desatting to 70's. 5L NC was placed so suctioning could occur, sats would not maintain over 70%, thick yellow sputum obtained by suction. Became tachy and transfered to ICU and intubated.  Acute on chronic hypoxemic resp failure s/t to ARDS d/t pneumonia vs pulm edema in setting of HFrEF and AMS. Current bilevel  setting FiO2 60%.  4/29/2022-Bilevel 16 25/10 35%. WBC and h&h stable. On Vanco cefepime and flagyl.  4/30/2022- recent echo showed severe L ventricular dilatation with moderate miral regurg EF 20%. Continue entresto hold toresemide 5/2/2022- Exubated on 2L NC. Continue cefepime and flagyl. 5/3/2022- WBC 15.4 from 13.3  ABG 7.453/31.9/66/22.3/90 cxr-pulmonary vascular congestion and cardiomegaly. Cont digoxin and metoprolol 5/5/2022- Transfered to ICU. Wears bipap at HS. o2 sat on 2L stable.  5/13/2022- Rapid response called  Acute RF, hypoxic 80's on sat , tachypneic using resp muscles. BP 154/104  RR 24  ABG 7.45/25/97/18/ on NRB  worsening CT chest -pulmonary infiltrates and b/l pleural effusion.  Bipap with PEEP 8.   Continued  distress, intubated and transfered to ICU. Chest Ct consisten with b/l diffuse groundglass opacities/  Covid + test.  Ferritin 535.0. Started on steroids, barcitinib, remdesivir, vitamins and heparin.  Cefepime and Vanco. 5/15/2022- Vent 12 22/6 60% 5/17/2022-Palliative orders placed d/t severe HF and mitral valve issues, fluid is in lungs and she is at high risk for reintubation if extubation is attempted. Terminally exubated. Morphine increased.  WBC 15.5  5/19/2022- Time of death  1003.
Age: 59.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Femur fracture, Fracture treatment, Fractured sacrum, Head injury, Immobile
Clinical narrative: 4/24/2022-Presented to ED, unwitnessed fall states hit head large hematoma on L eye, admitted to drinking alcohol daily. Confused. CT Had, R parafalcine subdural and L frontal/parietal subdural hygroma. CT-sacral fracture and L subtrochanteric femur fx. Covid -test.  Baseline 02 use 2L NC. Increased to 3L intermittently desat to mid 80's.Admit intraparenchymal hemorrhage with subdural hematoma s/t to fall.  4/25/2022-Left subtrochanteric hip fracture repair. R occiptal intraparenchymal hemorrhage inceased to 1.5cm L anterior frontal intraparenchymal hemorrhage increased to 5mm. No surgical intervention. BP controlled less then 140/80  currently 104/62, o2 sat 90's on 3L NC.  Keppra 750mg BID. ST eval clear liquids, swallowing difficulties. 4/26/2022- R occipital intraparenchymal hemorrhage  stable on f/u CT.  4/27/2022-On NRB, sat in mid 70's, o2 changed to 5L sata now 88-92%.  4/28/2022-AM-Mentation decline, desat 70-80 becoming more altered, fine wheezes bilateral and creptation on R side. Placed on NRB 15L. CXR-mod airpace disease/infiltrates  LAsix IV and levaquin , CT no evidence of PE. IVC filter placed to prevent PEd/t recent surgery and immobility.  PM-Sats in high 90's with NRB, but patient would not keep on, desatting to 70's. 5L NC was placed so suctioning could occur, sats would not maintain over 70%, thick yellow sputum obtained by suction. Became tachy and transfered to ICU and intubated.  Acute on chronic hypoxemic resp failure s/t to ARDS d/t pneumonia vs pulm edema in setting of HFrEF and AMS. Current bilevel  setting FiO2 60%.  4/29/2022-Bilevel 16 25/10 35%. WBC and h&h stable. On Vanco cefepime and flagyl.  4/30/2022- recent echo showed severe L ventricular dilatation with moderate miral regurg EF 20%. Continue entresto hold toresemide 5/2/2022- Exubated on 2L NC. Continue cefepime and flagyl. 5/3/2022- WBC 15.4 from 13.3  ABG 7.453/31.9/66/22.3/90 cxr-pulmonary vascular congestion and cardiomegaly. Cont digoxin and metoprolol 5/5/2022- Transfered to ICU. Wears bipap at HS. o2 sat on 2L stable.  5/13/2022- Rapid response called  Acute RF, hypoxic 80's on sat , tachypneic using resp muscles. BP 154/104  RR 24  ABG 7.45/25/97/18/ on NRB  worsening CT chest -pulmonary infiltrates and b/l pleural effusion.  Bipap with PEEP 8.   Continued  distress, intubated and transfered to ICU. Chest Ct consisten with b/l diffuse groundglass opacities/  Covid + test.  Ferritin 535.0. Started on steroids, barcitinib, remdesivir, vitamins and heparin.  Cefepime and Vanco. 5/15/2022- Vent 12 22/6 60% 5/17/2022-Palliative orders placed d/t severe HF and mitral valve issues, fluid is in lungs and she is at high risk for reintubation if extubation is attempted. Terminally exubated. Morphine increased.  WBC 15.5  5/19/2022- Time of death  1003.
Age: 59.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Intensive care, Left ventricular dilatation, Lung disorder, Lung infiltration, Lung opacity
Clinical narrative: 4/24/2022-Presented to ED, unwitnessed fall states hit head large hematoma on L eye, admitted to drinking alcohol daily. Confused. CT Had, R parafalcine subdural and L frontal/parietal subdural hygroma. CT-sacral fracture and L subtrochanteric femur fx. Covid -test.  Baseline 02 use 2L NC. Increased to 3L intermittently desat to mid 80's.Admit intraparenchymal hemorrhage with subdural hematoma s/t to fall.  4/25/2022-Left subtrochanteric hip fracture repair. R occiptal intraparenchymal hemorrhage inceased to 1.5cm L anterior frontal intraparenchymal hemorrhage increased to 5mm. No surgical intervention. BP controlled less then 140/80  currently 104/62, o2 sat 90's on 3L NC.  Keppra 750mg BID. ST eval clear liquids, swallowing difficulties. 4/26/2022- R occipital intraparenchymal hemorrhage  stable on f/u CT.  4/27/2022-On NRB, sat in mid 70's, o2 changed to 5L sata now 88-92%.  4/28/2022-AM-Mentation decline, desat 70-80 becoming more altered, fine wheezes bilateral and creptation on R side. Placed on NRB 15L. CXR-mod airpace disease/infiltrates  LAsix IV and levaquin , CT no evidence of PE. IVC filter placed to prevent PEd/t recent surgery and immobility.  PM-Sats in high 90's with NRB, but patient would not keep on, desatting to 70's. 5L NC was placed so suctioning could occur, sats would not maintain over 70%, thick yellow sputum obtained by suction. Became tachy and transfered to ICU and intubated.  Acute on chronic hypoxemic resp failure s/t to ARDS d/t pneumonia vs pulm edema in setting of HFrEF and AMS. Current bilevel  setting FiO2 60%.  4/29/2022-Bilevel 16 25/10 35%. WBC and h&h stable. On Vanco cefepime and flagyl.  4/30/2022- recent echo showed severe L ventricular dilatation with moderate miral regurg EF 20%. Continue entresto hold toresemide 5/2/2022- Exubated on 2L NC. Continue cefepime and flagyl. 5/3/2022- WBC 15.4 from 13.3  ABG 7.453/31.9/66/22.3/90 cxr-pulmonary vascular congestion and cardiomegaly. Cont digoxin and metoprolol 5/5/2022- Transfered to ICU. Wears bipap at HS. o2 sat on 2L stable.  5/13/2022- Rapid response called  Acute RF, hypoxic 80's on sat , tachypneic using resp muscles. BP 154/104  RR 24  ABG 7.45/25/97/18/ on NRB  worsening CT chest -pulmonary infiltrates and b/l pleural effusion.  Bipap with PEEP 8.   Continued  distress, intubated and transfered to ICU. Chest Ct consisten with b/l diffuse groundglass opacities/  Covid + test.  Ferritin 535.0. Started on steroids, barcitinib, remdesivir, vitamins and heparin.  Cefepime and Vanco. 5/15/2022- Vent 12 22/6 60% 5/17/2022-Palliative orders placed d/t severe HF and mitral valve issues, fluid is in lungs and she is at high risk for reintubation if extubation is attempted. Terminally exubated. Morphine increased.  WBC 15.5  5/19/2022- Time of death  1003.
Age: 59.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Mental status changes, Mitral valve incompetence, Oxygen saturation decreased, Pleural effusion, Pneumonia
Clinical narrative: 4/24/2022-Presented to ED, unwitnessed fall states hit head large hematoma on L eye, admitted to drinking alcohol daily. Confused. CT Had, R parafalcine subdural and L frontal/parietal subdural hygroma. CT-sacral fracture and L subtrochanteric femur fx. Covid -test.  Baseline 02 use 2L NC. Increased to 3L intermittently desat to mid 80's.Admit intraparenchymal hemorrhage with subdural hematoma s/t to fall.  4/25/2022-Left subtrochanteric hip fracture repair. R occiptal intraparenchymal hemorrhage inceased to 1.5cm L anterior frontal intraparenchymal hemorrhage increased to 5mm. No surgical intervention. BP controlled less then 140/80  currently 104/62, o2 sat 90's on 3L NC.  Keppra 750mg BID. ST eval clear liquids, swallowing difficulties. 4/26/2022- R occipital intraparenchymal hemorrhage  stable on f/u CT.  4/27/2022-On NRB, sat in mid 70's, o2 changed to 5L sata now 88-92%.  4/28/2022-AM-Mentation decline, desat 70-80 becoming more altered, fine wheezes bilateral and creptation on R side. Placed on NRB 15L. CXR-mod airpace disease/infiltrates  LAsix IV and levaquin , CT no evidence of PE. IVC filter placed to prevent PEd/t recent surgery and immobility.  PM-Sats in high 90's with NRB, but patient would not keep on, desatting to 70's. 5L NC was placed so suctioning could occur, sats would not maintain over 70%, thick yellow sputum obtained by suction. Became tachy and transfered to ICU and intubated.  Acute on chronic hypoxemic resp failure s/t to ARDS d/t pneumonia vs pulm edema in setting of HFrEF and AMS. Current bilevel  setting FiO2 60%.  4/29/2022-Bilevel 16 25/10 35%. WBC and h&h stable. On Vanco cefepime and flagyl.  4/30/2022- recent echo showed severe L ventricular dilatation with moderate miral regurg EF 20%. Continue entresto hold toresemide 5/2/2022- Exubated on 2L NC. Continue cefepime and flagyl. 5/3/2022- WBC 15.4 from 13.3  ABG 7.453/31.9/66/22.3/90 cxr-pulmonary vascular congestion and cardiomegaly. Cont digoxin and metoprolol 5/5/2022- Transfered to ICU. Wears bipap at HS. o2 sat on 2L stable.  5/13/2022- Rapid response called  Acute RF, hypoxic 80's on sat , tachypneic using resp muscles. BP 154/104  RR 24  ABG 7.45/25/97/18/ on NRB  worsening CT chest -pulmonary infiltrates and b/l pleural effusion.  Bipap with PEEP 8.   Continued  distress, intubated and transfered to ICU. Chest Ct consisten with b/l diffuse groundglass opacities/  Covid + test.  Ferritin 535.0. Started on steroids, barcitinib, remdesivir, vitamins and heparin.  Cefepime and Vanco. 5/15/2022- Vent 12 22/6 60% 5/17/2022-Palliative orders placed d/t severe HF and mitral valve issues, fluid is in lungs and she is at high risk for reintubation if extubation is attempted. Terminally exubated. Morphine increased.  WBC 15.5  5/19/2022- Time of death  1003.
Age: 59.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Positive airway pressure therapy, Positive end-expiratory pressure, Pulmonary congestion, Pulmonary oedema, Respiratory failure
Clinical narrative: 4/24/2022-Presented to ED, unwitnessed fall states hit head large hematoma on L eye, admitted to drinking alcohol daily. Confused. CT Had, R parafalcine subdural and L frontal/parietal subdural hygroma. CT-sacral fracture and L subtrochanteric femur fx. Covid -test.  Baseline 02 use 2L NC. Increased to 3L intermittently desat to mid 80's.Admit intraparenchymal hemorrhage with subdural hematoma s/t to fall.  4/25/2022-Left subtrochanteric hip fracture repair. R occiptal intraparenchymal hemorrhage inceased to 1.5cm L anterior frontal intraparenchymal hemorrhage increased to 5mm. No surgical intervention. BP controlled less then 140/80  currently 104/62, o2 sat 90's on 3L NC.  Keppra 750mg BID. ST eval clear liquids, swallowing difficulties. 4/26/2022- R occipital intraparenchymal hemorrhage  stable on f/u CT.  4/27/2022-On NRB, sat in mid 70's, o2 changed to 5L sata now 88-92%.  4/28/2022-AM-Mentation decline, desat 70-80 becoming more altered, fine wheezes bilateral and creptation on R side. Placed on NRB 15L. CXR-mod airpace disease/infiltrates  LAsix IV and levaquin , CT no evidence of PE. IVC filter placed to prevent PEd/t recent surgery and immobility.  PM-Sats in high 90's with NRB, but patient would not keep on, desatting to 70's. 5L NC was placed so suctioning could occur, sats would not maintain over 70%, thick yellow sputum obtained by suction. Became tachy and transfered to ICU and intubated.  Acute on chronic hypoxemic resp failure s/t to ARDS d/t pneumonia vs pulm edema in setting of HFrEF and AMS. Current bilevel  setting FiO2 60%.  4/29/2022-Bilevel 16 25/10 35%. WBC and h&h stable. On Vanco cefepime and flagyl.  4/30/2022- recent echo showed severe L ventricular dilatation with moderate miral regurg EF 20%. Continue entresto hold toresemide 5/2/2022- Exubated on 2L NC. Continue cefepime and flagyl. 5/3/2022- WBC 15.4 from 13.3  ABG 7.453/31.9/66/22.3/90 cxr-pulmonary vascular congestion and cardiomegaly. Cont digoxin and metoprolol 5/5/2022- Transfered to ICU. Wears bipap at HS. o2 sat on 2L stable.  5/13/2022- Rapid response called  Acute RF, hypoxic 80's on sat , tachypneic using resp muscles. BP 154/104  RR 24  ABG 7.45/25/97/18/ on NRB  worsening CT chest -pulmonary infiltrates and b/l pleural effusion.  Bipap with PEEP 8.   Continued  distress, intubated and transfered to ICU. Chest Ct consisten with b/l diffuse groundglass opacities/  Covid + test.  Ferritin 535.0. Started on steroids, barcitinib, remdesivir, vitamins and heparin.  Cefepime and Vanco. 5/15/2022- Vent 12 22/6 60% 5/17/2022-Palliative orders placed d/t severe HF and mitral valve issues, fluid is in lungs and she is at high risk for reintubation if extubation is attempted. Terminally exubated. Morphine increased.  WBC 15.5  5/19/2022- Time of death  1003.
Age: 59.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: SARS-CoV-2 test positive, Serum ferritin increased, Sputum abnormal, Sputum discoloured, Subdural haematoma
Clinical narrative: 4/24/2022-Presented to ED, unwitnessed fall states hit head large hematoma on L eye, admitted to drinking alcohol daily. Confused. CT Had, R parafalcine subdural and L frontal/parietal subdural hygroma. CT-sacral fracture and L subtrochanteric femur fx. Covid -test.  Baseline 02 use 2L NC. Increased to 3L intermittently desat to mid 80's.Admit intraparenchymal hemorrhage with subdural hematoma s/t to fall.  4/25/2022-Left subtrochanteric hip fracture repair. R occiptal intraparenchymal hemorrhage inceased to 1.5cm L anterior frontal intraparenchymal hemorrhage increased to 5mm. No surgical intervention. BP controlled less then 140/80  currently 104/62, o2 sat 90's on 3L NC.  Keppra 750mg BID. ST eval clear liquids, swallowing difficulties. 4/26/2022- R occipital intraparenchymal hemorrhage  stable on f/u CT.  4/27/2022-On NRB, sat in mid 70's, o2 changed to 5L sata now 88-92%.  4/28/2022-AM-Mentation decline, desat 70-80 becoming more altered, fine wheezes bilateral and creptation on R side. Placed on NRB 15L. CXR-mod airpace disease/infiltrates  LAsix IV and levaquin , CT no evidence of PE. IVC filter placed to prevent PEd/t recent surgery and immobility.  PM-Sats in high 90's with NRB, but patient would not keep on, desatting to 70's. 5L NC was placed so suctioning could occur, sats would not maintain over 70%, thick yellow sputum obtained by suction. Became tachy and transfered to ICU and intubated.  Acute on chronic hypoxemic resp failure s/t to ARDS d/t pneumonia vs pulm edema in setting of HFrEF and AMS. Current bilevel  setting FiO2 60%.  4/29/2022-Bilevel 16 25/10 35%. WBC and h&h stable. On Vanco cefepime and flagyl.  4/30/2022- recent echo showed severe L ventricular dilatation with moderate miral regurg EF 20%. Continue entresto hold toresemide 5/2/2022- Exubated on 2L NC. Continue cefepime and flagyl. 5/3/2022- WBC 15.4 from 13.3  ABG 7.453/31.9/66/22.3/90 cxr-pulmonary vascular congestion and cardiomegaly. Cont digoxin and metoprolol 5/5/2022- Transfered to ICU. Wears bipap at HS. o2 sat on 2L stable.  5/13/2022- Rapid response called  Acute RF, hypoxic 80's on sat , tachypneic using resp muscles. BP 154/104  RR 24  ABG 7.45/25/97/18/ on NRB  worsening CT chest -pulmonary infiltrates and b/l pleural effusion.  Bipap with PEEP 8.   Continued  distress, intubated and transfered to ICU. Chest Ct consisten with b/l diffuse groundglass opacities/  Covid + test.  Ferritin 535.0. Started on steroids, barcitinib, remdesivir, vitamins and heparin.  Cefepime and Vanco. 5/15/2022- Vent 12 22/6 60% 5/17/2022-Palliative orders placed d/t severe HF and mitral valve issues, fluid is in lungs and she is at high risk for reintubation if extubation is attempted. Terminally exubated. Morphine increased.  WBC 15.5  5/19/2022- Time of death  1003.
Age: 59.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Subdural hygroma, Tachycardia, Use of accessory respiratory muscles, Vena cava filter insertion, Wheezing
Clinical narrative: 4/24/2022-Presented to ED, unwitnessed fall states hit head large hematoma on L eye, admitted to drinking alcohol daily. Confused. CT Had, R parafalcine subdural and L frontal/parietal subdural hygroma. CT-sacral fracture and L subtrochanteric femur fx. Covid -test.  Baseline 02 use 2L NC. Increased to 3L intermittently desat to mid 80's.Admit intraparenchymal hemorrhage with subdural hematoma s/t to fall.  4/25/2022-Left subtrochanteric hip fracture repair. R occiptal intraparenchymal hemorrhage inceased to 1.5cm L anterior frontal intraparenchymal hemorrhage increased to 5mm. No surgical intervention. BP controlled less then 140/80  currently 104/62, o2 sat 90's on 3L NC.  Keppra 750mg BID. ST eval clear liquids, swallowing difficulties. 4/26/2022- R occipital intraparenchymal hemorrhage  stable on f/u CT.  4/27/2022-On NRB, sat in mid 70's, o2 changed to 5L sata now 88-92%.  4/28/2022-AM-Mentation decline, desat 70-80 becoming more altered, fine wheezes bilateral and creptation on R side. Placed on NRB 15L. CXR-mod airpace disease/infiltrates  LAsix IV and levaquin , CT no evidence of PE. IVC filter placed to prevent PEd/t recent surgery and immobility.  PM-Sats in high 90's with NRB, but patient would not keep on, desatting to 70's. 5L NC was placed so suctioning could occur, sats would not maintain over 70%, thick yellow sputum obtained by suction. Became tachy and transfered to ICU and intubated.  Acute on chronic hypoxemic resp failure s/t to ARDS d/t pneumonia vs pulm edema in setting of HFrEF and AMS. Current bilevel  setting FiO2 60%.  4/29/2022-Bilevel 16 25/10 35%. WBC and h&h stable. On Vanco cefepime and flagyl.  4/30/2022- recent echo showed severe L ventricular dilatation with moderate miral regurg EF 20%. Continue entresto hold toresemide 5/2/2022- Exubated on 2L NC. Continue cefepime and flagyl. 5/3/2022- WBC 15.4 from 13.3  ABG 7.453/31.9/66/22.3/90 cxr-pulmonary vascular congestion and cardiomegaly. Cont digoxin and metoprolol 5/5/2022- Transfered to ICU. Wears bipap at HS. o2 sat on 2L stable.  5/13/2022- Rapid response called  Acute RF, hypoxic 80's on sat , tachypneic using resp muscles. BP 154/104  RR 24  ABG 7.45/25/97/18/ on NRB  worsening CT chest -pulmonary infiltrates and b/l pleural effusion.  Bipap with PEEP 8.   Continued  distress, intubated and transfered to ICU. Chest Ct consisten with b/l diffuse groundglass opacities/  Covid + test.  Ferritin 535.0. Started on steroids, barcitinib, remdesivir, vitamins and heparin.  Cefepime and Vanco. 5/15/2022- Vent 12 22/6 60% 5/17/2022-Palliative orders placed d/t severe HF and mitral valve issues, fluid is in lungs and she is at high risk for reintubation if extubation is attempted. Terminally exubated. Morphine increased.  WBC 15.5  5/19/2022- Time of death  1003.
Age: 59.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: White blood cell count increased
Clinical narrative: 4/24/2022-Presented to ED, unwitnessed fall states hit head large hematoma on L eye, admitted to drinking alcohol daily. Confused. CT Had, R parafalcine subdural and L frontal/parietal subdural hygroma. CT-sacral fracture and L subtrochanteric femur fx. Covid -test.  Baseline 02 use 2L NC. Increased to 3L intermittently desat to mid 80's.Admit intraparenchymal hemorrhage with subdural hematoma s/t to fall.  4/25/2022-Left subtrochanteric hip fracture repair. R occiptal intraparenchymal hemorrhage inceased to 1.5cm L anterior frontal intraparenchymal hemorrhage increased to 5mm. No surgical intervention. BP controlled less then 140/80  currently 104/62, o2 sat 90's on 3L NC.  Keppra 750mg BID. ST eval clear liquids, swallowing difficulties. 4/26/2022- R occipital intraparenchymal hemorrhage  stable on f/u CT.  4/27/2022-On NRB, sat in mid 70's, o2 changed to 5L sata now 88-92%.  4/28/2022-AM-Mentation decline, desat 70-80 becoming more altered, fine wheezes bilateral and creptation on R side. Placed on NRB 15L. CXR-mod airpace disease/infiltrates  LAsix IV and levaquin , CT no evidence of PE. IVC filter placed to prevent PEd/t recent surgery and immobility.  PM-Sats in high 90's with NRB, but patient would not keep on, desatting to 70's. 5L NC was placed so suctioning could occur, sats would not maintain over 70%, thick yellow sputum obtained by suction. Became tachy and transfered to ICU and intubated.  Acute on chronic hypoxemic resp failure s/t to ARDS d/t pneumonia vs pulm edema in setting of HFrEF and AMS. Current bilevel  setting FiO2 60%.  4/29/2022-Bilevel 16 25/10 35%. WBC and h&h stable. On Vanco cefepime and flagyl.  4/30/2022- recent echo showed severe L ventricular dilatation with moderate miral regurg EF 20%. Continue entresto hold toresemide 5/2/2022- Exubated on 2L NC. Continue cefepime and flagyl. 5/3/2022- WBC 15.4 from 13.3  ABG 7.453/31.9/66/22.3/90 cxr-pulmonary vascular congestion and cardiomegaly. Cont digoxin and metoprolol 5/5/2022- Transfered to ICU. Wears bipap at HS. o2 sat on 2L stable.  5/13/2022- Rapid response called  Acute RF, hypoxic 80's on sat , tachypneic using resp muscles. BP 154/104  RR 24  ABG 7.45/25/97/18/ on NRB  worsening CT chest -pulmonary infiltrates and b/l pleural effusion.  Bipap with PEEP 8.   Continued  distress, intubated and transfered to ICU. Chest Ct consisten with b/l diffuse groundglass opacities/  Covid + test.  Ferritin 535.0. Started on steroids, barcitinib, remdesivir, vitamins and heparin.  Cefepime and Vanco. 5/15/2022- Vent 12 22/6 60% 5/17/2022-Palliative orders placed d/t severe HF and mitral valve issues, fluid is in lungs and she is at high risk for reintubation if extubation is attempted. Terminally exubated. Morphine increased.  WBC 15.5  5/19/2022- Time of death  1003.
Age: 5.0
Sex: M
Vaccine: COVID19
Symptoms: Incorrect dose administered, Product administered to patient of inappropriate age
Clinical narrative: Patient is 5 years old and was accidentally given the Pfizer dosage for the age group 6 months-4 years.  Parent is aware. According to CDC, advised redosing after 8 weeks of lower dosage administered.
Age: 81.0
Sex: M
Vaccine: UNK
Symptoms: Asthenia
Clinical narrative: weakness
Age: 75.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Chest X-ray normal, Illness, Loss of consciousness, Malaise
Clinical narrative: I experienced COVID-19 after my vaccine. I had PAXLOVID. I caught Covid on a trip I took. I went to urgent care three times to get chest x-ray because my oxygen level were so low. I felt very ill. I also fainted and passed out. The third time I went to the ER is because I needed albuterol which helped me a lot. This is the sickness I ever been in my life and I am still not very well.
Age: 75.0
Sex: F
Vaccine: COVID19
Symptoms: Oxygen saturation decreased, Syncope
Clinical narrative: I experienced COVID-19 after my vaccine. I had PAXLOVID. I caught Covid on a trip I took. I went to urgent care three times to get chest x-ray because my oxygen level were so low. I felt very ill. I also fainted and passed out. The third time I went to the ER is because I needed albuterol which helped me a lot. This is the sickness I ever been in my life and I am still not very well.
Age: 82.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Acute respiratory failure, Angiogram pulmonary abnormal, Anticoagulant therapy, Atrial fibrillation, Body temperature increased
Clinical narrative: 4/28/2022-Sent by ortho  was going to have surgical treatment of chin on chest deformity referabl to subluxation spondylolisthesis at C7-T1 with cord compression.  Temp-101, HR 128 and RR-28 spo2 around 88 on 3L NC. Baseline oxygen use HS. Covid + test. CRP-15.6 and WBC-13.7 CTA no PE but b/l infiltrate concerning for pneumonia. New onset paroxysmal a fib with chronic St-T wave changes, rate is controlled, continue home dose of COreg. Admit sepsis and acute hypoxic resp failure d/t b/l pneumonia. Administered  decadron, remdesivir, Lovenox, ceftriaxone and doxy. 5/2/2022- Cont. IP stay, remains on 3L nc spo2 above 90%. 5/3/2022-Vitals WNL. CRP-1.7 and WBC-12.4    maintaining spo2 on 3L . D/C to home, will follow up with ortho to have surgery
Age: 82.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: C-reactive protein increased, COVID-19, Electrocardiogram ST-T segment abnormal, Lung infiltration, Pneumonia
Clinical narrative: 4/28/2022-Sent by ortho  was going to have surgical treatment of chin on chest deformity referabl to subluxation spondylolisthesis at C7-T1 with cord compression.  Temp-101, HR 128 and RR-28 spo2 around 88 on 3L NC. Baseline oxygen use HS. Covid + test. CRP-15.6 and WBC-13.7 CTA no PE but b/l infiltrate concerning for pneumonia. New onset paroxysmal a fib with chronic St-T wave changes, rate is controlled, continue home dose of COreg. Admit sepsis and acute hypoxic resp failure d/t b/l pneumonia. Administered  decadron, remdesivir, Lovenox, ceftriaxone and doxy. 5/2/2022- Cont. IP stay, remains on 3L nc spo2 above 90%. 5/3/2022-Vitals WNL. CRP-1.7 and WBC-12.4    maintaining spo2 on 3L . D/C to home, will follow up with ortho to have surgery
Age: 82.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: SARS-CoV-2 test positive, Sepsis, White blood cell count increased
Clinical narrative: 4/28/2022-Sent by ortho  was going to have surgical treatment of chin on chest deformity referabl to subluxation spondylolisthesis at C7-T1 with cord compression.  Temp-101, HR 128 and RR-28 spo2 around 88 on 3L NC. Baseline oxygen use HS. Covid + test. CRP-15.6 and WBC-13.7 CTA no PE but b/l infiltrate concerning for pneumonia. New onset paroxysmal a fib with chronic St-T wave changes, rate is controlled, continue home dose of COreg. Admit sepsis and acute hypoxic resp failure d/t b/l pneumonia. Administered  decadron, remdesivir, Lovenox, ceftriaxone and doxy. 5/2/2022- Cont. IP stay, remains on 3L nc spo2 above 90%. 5/3/2022-Vitals WNL. CRP-1.7 and WBC-12.4    maintaining spo2 on 3L . D/C to home, will follow up with ortho to have surgery
Age: 19.0
Sex: M
Vaccine: HEPA, HEPA
Symptoms: Incorrect dose administered, Underdose
Clinical narrative: Patient was given pediatric dose of Hepatitis A instead of an adult dose. Verified with pharmacy to give another pediatric dose (0.5mL) of Hepatitis A to equal one adult dose (1mL). So patient was given two pediatric doses (0.5mL each) in total.
Age: 67.0
Sex: M
Vaccine: COVID19-2
Symptoms: Fatigue, Testicular swelling
Clinical narrative: EXTREME FATIGUE ENLARGED TESTICLE - WAS DIRECTED TO CALL DOCTOR TO SEE IF THEY BELIEVED A VISIT WAS NECESSARY
Age: 64.0
Sex: M
Vaccine: COVID19-2
Symptoms: Death, Malaise, Pallor, Unresponsive to stimuli
Clinical narrative: death: At 1745 staff alerted writer to come into resident's room because he was not doing well. resident's vitals as follows; Temp 97.3, BP 114/71, HR 141, RR 42, O2 saturation 35%. Resident was ashen in color and was unresponsive. Hospice was called. The DON was updated on resident's change in condition and a confidential message was left for the professional guardian,
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Incorrect product formulation administered, No adverse event
Clinical narrative: Patient was administered the initial COVID-19 vaccine instead of the booster dose. No adverse events reported.
Age: 75.0
Sex: F
Vaccine: COVID19-2
Symptoms: No adverse event, Wrong product administered
Clinical narrative: Pt was at clinic to receive her initial Covid 19 vaccine. Order was entered for monovalent vaccine however Bivalent vaccine was given. Pt arrived at another clinic on 10/7/22 to receive her 2nd Covid vaccine when the error was discovered. Director of Pharmacy was notified and after researching the issue the decision was made to give the patient a dose of the monovalent vaccine on her next visit. Patient has had no adverse effects.
Age: 64.0
Sex: M
Vaccine: COVID19
Symptoms: Body temperature increased
Clinical narrative: On 1/26/22 patient was assessed and was found to hav ea temp of 101.1. Tylenol was given and temp dropped to 100.8.
Age: 66.0
Sex: F
Vaccine: COVID19-2, FLU4
Symptoms: Herpes zoster, Paraesthesia, Skin lesion
Clinical narrative: Begining on 10/12 I began feeling a tingling on left eyelid.  The following 2 day developed small lesions.  I had had a previous Shingles outbreak in the same area years before with significan post heptic pain.  I was traveling but went to an urgent care clinic as advised by my home  physician.  I was positively diagnosed with shinlges and given Valacyclovir.
Age: 49.0
Sex: F
Vaccine: COVID19-2, FLUC4
Symptoms: Diarrhoea, Dizziness, Fatigue, Nausea
Clinical narrative: Nausea, lightheadness, fatigue, diarrhea
Age: 60.0
Sex: F
Vaccine: COVID19-2
Symptoms: Injection site pain, Myalgia
Clinical narrative: 1 week and 1 day after the vaccination was administered, my upper left arm became extremely sore (muscle achiness, but without any swelling, redness or heat). This lasted for 2 days and resolved by the third day. I took Advil to reduce the pain.  I had received 3 Moderna vaccines before this Pfizer Bivalent booster and never had this type of a reaction.
Age: 70.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Injected limb mobility decreased, Peripheral swelling
Clinical narrative: arm  swollen - cant raise arm; not functioning correctly since shot
Age: 70.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Magnetic resonance imaging, Mobility decreased, Muscle tightness, Musculoskeletal stiffness, Myalgia
Clinical narrative: arm  swollen - cant raise arm; not functioning correctly since shot
Age: 70.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Pain, X-ray
Clinical narrative: arm  swollen - cant raise arm; not functioning correctly since shot
Age: 63.0
Sex: M
Vaccine: SMALLMNK
Symptoms: Extra dose administered, Wrong technique in product usage process
Clinical narrative: Did not receive the wheel upon administration.  Repeat dose provided to success.
Age: 66.0
Sex: F
Vaccine: FLU4
Symptoms: Erythema, Pain in extremity, Peripheral swelling
Clinical narrative: soreness, swelling, redness. all the way down to my elbow for a week
Age: 62.0
Sex: F
Vaccine: COVID19-2
Symptoms: COVID-19, Dysphagia, Fatigue, Headache, Pain
Clinical narrative: At 1 in the morning on 10/09/2022 I woke up with a thick throat and had a hard time swallowing. The same morning, I woke up with body aches and just very felt fatigue with a slight headache. I took a at home test shortly after waking up and right away the results were positive. I called the nurse hotline, and they were able to prescribe Paxlovid since it was a Sunday. The symptoms were getting worse throughout the day and had me in the bed. After picking up my prescription the very next day I felt absolutely fine. I tested 3 days in a row, and they were all positive. Then I waited until I completed my prescription and tested 10/16/2022 it came back negative.
Age: 62.0
Sex: F
Vaccine: COVID19-2
Symptoms: Pharyngeal swelling, SARS-CoV-2 test positive
Clinical narrative: At 1 in the morning on 10/09/2022 I woke up with a thick throat and had a hard time swallowing. The same morning, I woke up with body aches and just very felt fatigue with a slight headache. I took a at home test shortly after waking up and right away the results were positive. I called the nurse hotline, and they were able to prescribe Paxlovid since it was a Sunday. The symptoms were getting worse throughout the day and had me in the bed. After picking up my prescription the very next day I felt absolutely fine. I tested 3 days in a row, and they were all positive. Then I waited until I completed my prescription and tested 10/16/2022 it came back negative.
Age: 59.0
Sex: M
Vaccine: FLU4
Symptoms: Pain in extremity, Wrong product administered
Clinical narrative: Pt asked for a Flublok vaccine.  I gave him a Fluzone HD.   The boxes look similar, and the peel-off stickers look almost identical. I called him about 48 hours later and he said his only side effect was a "sore arm." No treatment.
Age: 36.0
Sex: M
Vaccine: FLU4
Symptoms: Abdominal pain lower, Back pain, CSF lymphocyte count increased, CSF white blood cell count increased, Computerised tomogram abdomen normal
Clinical narrative: 10 days after vaccine administration patient developed left lower quadrant pain and back pain which quickly progressed to bilateral flaccid paralysis of lower extremities. MRI shows acute demyelinating myelitis vs transverse myelitis.
Age: 36.0
Sex: M
Vaccine: FLU4
Symptoms: Culture negative, Immunology test normal, Laboratory test normal, Lumbar puncture, Magnetic resonance imaging spinal abnormal
Clinical narrative: 10 days after vaccine administration patient developed left lower quadrant pain and back pain which quickly progressed to bilateral flaccid paralysis of lower extremities. MRI shows acute demyelinating myelitis vs transverse myelitis.
Age: 36.0
Sex: M
Vaccine: FLU4
Symptoms: Myelitis, Myelitis transverse, Paralysis, Viral test negative
Clinical narrative: 10 days after vaccine administration patient developed left lower quadrant pain and back pain which quickly progressed to bilateral flaccid paralysis of lower extremities. MRI shows acute demyelinating myelitis vs transverse myelitis.
Age: 64.0
Sex: F
Vaccine: UNK, VARZOS
Symptoms: Asthenia, Chills, Dyspnoea, Dyspnoea exertional, Headache
Clinical narrative: Chills, weakness, shortness of breath, high heart rate (even though the pacemaker controls the heart) headache.  I can't climb stairs without having trouble breathing. I feel like I have the flu. The spot where I got the shot stayed red and hot until this morning and was almost down to my elbow.
Age: 64.0
Sex: F
Vaccine: UNK, VARZOS
Symptoms: Heart rate increased, Influenza like illness, Injection site erythema, Injection site warmth
Clinical narrative: Chills, weakness, shortness of breath, high heart rate (even though the pacemaker controls the heart) headache.  I can't climb stairs without having trouble breathing. I feel like I have the flu. The spot where I got the shot stayed red and hot until this morning and was almost down to my elbow.
Age: 64.0
Sex: F
Vaccine: UNK, VARZOS
Symptoms: Asthenia, Chills, Erythema, Heart rate increased, Influenza like illness
Clinical narrative: Chills, weakness, shortness of breath, high heart rate (even though the pacemaker controls the heart) headache.  I can't climb stairs without having trouble breathing. I feel like I have the flu. The spot where I got the shot stayed red and hot until this morning and was almost down to my elbow.
Age: 64.0
Sex: F
Vaccine: UNK, VARZOS
Symptoms: Peripheral swelling, Pyrexia, Rhinorrhoea, Skin warm
Clinical narrative: Chills, weakness, shortness of breath, high heart rate (even though the pacemaker controls the heart) headache.  I can't climb stairs without having trouble breathing. I feel like I have the flu. The spot where I got the shot stayed red and hot until this morning and was almost down to my elbow.
Age: 43.0
Sex: M
Vaccine: FLUA4
Symptoms: Product administered to patient of inappropriate age
Clinical narrative: Patient given high dose flu vaccine at 43 years of age, so does not meet minimum age requirement approved for this vaccine.  Vaccine was given at a drive thru  mass flu clinic by a volunteer nurse practitioner.  NP is not employed by  Health Department.
Age: 64.0
Sex: M
Vaccine: COVID19
Symptoms: No adverse event
Clinical narrative: there was NO adverse event.  apparently I did not read a question carefully enough on the text check-ins that I signed up for - I have had NO adverse effect from the vaccine nor boosters
Age: 45.0
Sex: M
Vaccine: FLU4
Symptoms: Rash papular, Skin lesion
Clinical narrative: Patient reported that he developed a rash approximately 24 hours post vaccination. Patient observed to have 5 or less papular lesions across forearms and hands. Patient reported the symptoms 11 days after vaccination date.